- Home
- KROS vs ECX Comparison
KROS vs ECX Comparison
Compare KROS & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | ECX |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 643.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | ECX |
|---|---|---|
| Price | $21.01 | $1.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $22.20 | $3.20 |
| AVG Volume (30 Days) | 790.2K | ★ 3.9M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | $246,718,000.00 | ★ $822,663,229.00 |
| Revenue This Year | $6,924.79 | $772.81 |
| Revenue Next Year | N/A | $30.47 |
| P/E Ratio | $13.35 | ★ N/A |
| Revenue Growth | ★ 37798.31 | 6.99 |
| 52 Week Low | $9.12 | $0.76 |
| 52 Week High | $22.55 | $3.25 |
Technical Indicators
Market Signals| Indicator | KROS | ECX |
|---|---|---|
| Relative Strength Index (RSI) | 61.60 | 38.04 |
| Support Level | $19.76 | $1.58 |
| Resistance Level | $21.76 | $1.79 |
| Average True Range (ATR) | 0.82 | 0.14 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 46.59 | 7.38 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.